Earnest Partners LLC cut its holdings in shares of Agilent Technologies Inc (NYSE:A) by 0.8% during the 4th quarter, Holdings Channel reports. The firm owned 375,174 shares of the medical research company’s stock after selling 3,006 shares during the quarter. Earnest Partners LLC’s holdings in Agilent Technologies were worth $25,125,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of A. Sumitomo Mitsui Trust Holdings Inc. grew its position in shares of Agilent Technologies by 9.9% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 998,225 shares of the medical research company’s stock worth $64,086,000 after acquiring an additional 90,317 shares in the last quarter. Timber Hill LLC acquired a new position in shares of Agilent Technologies in the 3rd quarter worth approximately $1,672,000. Chevy Chase Trust Holdings Inc. grew its position in shares of Agilent Technologies by 0.9% in the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 282,115 shares of the medical research company’s stock worth $18,112,000 after acquiring an additional 2,599 shares in the last quarter. WCM Investment Management CA grew its position in shares of Agilent Technologies by 8.5% in the 3rd quarter. WCM Investment Management CA now owns 721,036 shares of the medical research company’s stock worth $46,290,000 after acquiring an additional 56,589 shares in the last quarter. Finally, Twin Capital Management Inc. acquired a new position in shares of Agilent Technologies in the 3rd quarter worth approximately $2,153,000.
In other Agilent Technologies news, CEO Michael R. Mcmullen sold 21,850 shares of the business’s stock in a transaction on Monday, January 29th. The stock was sold at an average price of $75.00, for a total transaction of $1,638,750.00. Following the completion of the transaction, the chief executive officer now owns 324,687 shares in the company, valued at approximately $24,351,525. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Mark Doak sold 15,567 shares of the business’s stock in a transaction on Monday, December 18th. The stock was sold at an average price of $68.00, for a total value of $1,058,556.00. Following the transaction, the insider now owns 71,104 shares of the company’s stock, valued at approximately $4,835,072. The disclosure for this sale can be found here. Insiders have sold a total of 102,970 shares of company stock valued at $7,340,641 in the last quarter.
Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 14th. The medical research company reported $0.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.58 by $0.08. Agilent Technologies had a return on equity of 17.70% and a net margin of 4.25%. The company had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.16 billion. During the same quarter in the previous year, the firm posted $0.53 EPS. equities analysts forecast that Agilent Technologies Inc will post 2.68 earnings per share for the current fiscal year.
A has been the subject of several research reports. Morgan Stanley reiterated an “overweight” rating on shares of Agilent Technologies in a research report on Tuesday, November 14th. Zacks Investment Research lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Thursday, November 16th. Deutsche Bank set a $75.00 price objective on Agilent Technologies and gave the company a “buy” rating in a research report on Tuesday, November 21st. JPMorgan Chase & Co. boosted their price objective on Agilent Technologies to $75.00 and gave the company an “overweight” rating in a research report on Tuesday, November 21st. Finally, Barclays boosted their price objective on Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a research report on Tuesday, November 21st. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Agilent Technologies presently has a consensus rating of “Buy” and an average price target of $71.27.
TRADEMARK VIOLATION NOTICE: “Earnest Partners LLC Has $25.13 Million Holdings in Agilent Technologies Inc (A)” was originally posted by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.themarketsdaily.com/2018/03/14/earnest-partners-llc-has-25-13-million-holdings-in-agilent-technologies-inc-a.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.